3 diagnostic and therapeutic radiopharmaceuticals for brain tumors were unveiled by the Atomic Energy Organization
| Three drugs for the diagnosis and treatment of brain tumors were unveiled by the Atomic Energy Organization in the presence of Mohammad Eslami, the head of this organization, in Mossali, Tehran. |
according to the report of the international group Tasnim news agency, according to the report Tasnim News Agency foreign policy reporter, today, Tuesday, the unveiling ceremony of the achievements of the Atomic Energy Organization in the field of radiopharmaceuticals with the presence of Mohammad Eslami, deputy The president and head of the Atomic Energy Organization of Iran and Amirhossein Faqhi, the deputy head of the Atomic Energy Organization and the head of the Nuclear Science and Technology Research Institute, were held at the research, technology and art market exhibition in Imam Khomeini Mosque.
The diagnostic radiopharmaceutical 64Cu-DOTATATE, the new diagnostic peptide radiopharmaceutical 64Cu-PSMA, and the therapeutic radiopharmaceutical 177Lu-CXCR4 are three that can be used to diagnose brain tumors that were unveiled today.
| Publisher | Tasnim News |
|
